How should I manage a patient who presents with facial angioedema?

Management of Facial Angioedema

Immediately assess airway patency and prepare for intubation if there is any oropharyngeal or laryngeal involvement, as this represents a life-threatening emergency with potential for complete airway obstruction. 1

Initial Assessment and Airway Management

The first priority is determining whether the angioedema threatens the airway. Facial angioedema can rapidly progress to involve the oropharynx and larynx, leading to asphyxiation and death. Patients with any signs of tongue, throat, or laryngeal swelling require:

• Continuous monitoring in a controlled environment
• Low threshold for early intubation before complete airway obstruction occurs
• Avoid waiting for medical therapy to work if airway compromise is imminent 1

Determine the Underlying Mechanism

Angioedema management depends critically on identifying whether it is histamine-mediated or bradykinin-mediated, as treatments differ fundamentally:

Key Distinguishing Features:

Bradykinin-mediated angioedema:

• No urticaria or pruritus (this is the critical distinguishing feature) 1
• Asymmetric, non-dependent swelling
• Involves face, tongue, extremities, abdomen, or genitourinary tract
• Progresses over 24 hours, peaks, then resolves over 48-72 hours 1
• Does NOT respond to epinephrine, antihistamines, or corticosteroids 1

Histamine-mediated angioedema:

• Usually accompanied by urticaria or pruritus
• Responds to antihistamines
• Often part of allergic reaction or chronic urticaria spectrum 1

Medication History: ACE Inhibitor-Induced Angioedema

Immediately ask if the patient is taking an ACE inhibitor or ARB - this is the most common cause of bradykinin-mediated angioedema. 1

ACE inhibitor-induced angioedema:

• Occurs in 0.1-0.7% of patients on ACE inhibitors 1
• Can occur within the first month OR after years of therapy 1
• Predominantly affects face and tongue 1
• Higher risk in: African Americans, smokers, older patients, females 1
• Management: Discontinue the ACE inhibitor immediately (or ARB if applicable) 1
• Critical caveat: Propensity to swell can continue for at least 6 weeks after discontinuation 1

Treatment for ACE Inhibitor-Induced Angioedema:

• Discontinue the offending drug 1
• Observe in controlled environment for potential intubation 1
• Do NOT use epinephrine, antihistamines, or corticosteroids - they are ineffective 1
• Consider icatibant (bradykinin B2 receptor antagonist) or fresh frozen plasma - open-label reports show efficacy, though no controlled trials exist 1
• Tranexamic acid 1g IV has shown marked improvement in case reports, with resolution within 30 minutes to 2 hours 2

Important: Most patients who had ACE inhibitor-induced angioedema can safely switch to ARBs, though a modest risk of recurrence exists 1

Hereditary Angioedema (HAE)

If angioedema is recurrent, without urticaria, and not ACE inhibitor-related, suspect HAE and obtain diagnostic testing:

Diagnostic Testing:

• C4 level (screening test - will be low in HAE)
• C1 inhibitor antigenic level
• C1 inhibitor functional level
• C1q level (normal in HAE, low in acquired C1 inhibitor deficiency) 1

Type I HAE: Low C1INH antigen AND low C1INH function (most common)
Type II HAE: Normal C1INH antigen BUT low C1INH function 1

Clinical Features of HAE:

• Onset typically in childhood, worsens around puberty 1
• Autosomal dominant - positive family history in most cases 1
• Episodes involve extremities, abdomen, face, oropharynx, or larynx 1
• Abdominal attacks cause severe pain, vomiting, hypotension - often lead to unnecessary surgery 1
• Historical mortality from laryngeal edema: 30% 1

Treatment of Acute HAE Attacks:

Critical principle: Epinephrine, corticosteroids, and antihistamines are NOT efficacious and NOT recommended 1

Effective treatments (all have Level A evidence): 1

• C1 inhibitor concentrate (plasma-derived or recombinant)
• Icatibant (bradykinin B2 receptor antagonist)
• Ecallantide (plasma kallikrein inhibitor)

All patients with HAE should have access to on-demand HAE-specific therapy - this is emphasized in US and international consensus guidelines 1

Fresh frozen plasma can be effective but may paradoxically worsen some attacks - use with caution 1

Histamine-Mediated Angioedema (with Urticaria)

If urticaria or pruritus is present:

• Epinephrine IM (for anaphylaxis or severe cases)
• Antihistamines (H1 blockers)
• Corticosteroids
• Consider this part of chronic urticaria spectrum if recurrent 1

Common Pitfalls to Avoid

1. Delaying intubation in patients with oropharyngeal involvement - intubate early before complete obstruction
2. Using epinephrine/antihistamines/steroids for bradykinin-mediated angioedema - they don't work and waste critical time 1
3. Failing to ask about ACE inhibitors - this is the most common reversible cause 1
4. Not recognizing HAE - leads to repeated unnecessary surgeries for abdominal attacks and preventable deaths from laryngeal edema 1
5. Assuming ACE inhibitor angioedema will resolve immediately after stopping the drug - swelling propensity continues for 6+ weeks 1
6. Performing unnecessary abdominal surgery in HAE patients with abdominal attacks 1

Disposition

• Any airway involvement: Admit for observation, ICU if severe
• ACE inhibitor-induced: Observe in controlled setting, discontinue drug, arrange follow-up
• Suspected HAE: Refer to allergy/immunology for diagnostic workup and long-term management
• Histamine-mediated with good response: May discharge with antihistamines and epinephrine auto-injector if appropriate